{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:20:30Z","timestamp":1783488030325,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.clnu.2023.10.015","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T03:47:51Z","timestamp":1697600871000},"page":"2468-2474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["A prospective study to assess the impact of a novel CFTR therapy combination on body composition in patients with cystic fibrosis with F508del mutation"],"prefix":"10.1016","volume":"42","author":[{"given":"Carolina","family":"Knott-Torcal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4127-0483","authenticated-orcid":false,"given":"Fernando","family":"Sebasti\u00e1n-Valles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7094-0848","authenticated-orcid":false,"given":"Rosa Mar\u00eda","family":"Gir\u00f3n Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Carlos","family":"Mart\u00edn- Ad\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8516-2695","authenticated-orcid":false,"given":"Jessica","family":"Jim\u00e9nez-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5829-1582","authenticated-orcid":false,"given":"M\u00f3nica","family":"Marazuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"S\u00e1nchez de la Blanca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9087-3355","authenticated-orcid":false,"given":"Ra\u00fal","family":"Fern\u00e1ndez-Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0140-1522","authenticated-orcid":false,"given":"Alfonso","family":"Arranz-Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10212","key":"10.1016\/j.clnu.2023.10.015_bib1","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.clnu.2023.10.015_bib2","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.jand.2020.03.014","article-title":"Effect of CFTR modulators on anthropometric parameters in individuals with cystic fibrosis: an evidence analysis center systematic review","volume":"121","author":"Bailey","year":"2021","journal-title":"J\u00a0Acad Nutr Diet [Internet]"},{"issue":"9","key":"10.1016\/j.clnu.2023.10.015_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ph14090928","article-title":"State of the art on approved cystic fibrosis transmembrane conductance regulator (Cftr) modulators and triple-combination therapy","volume":"14","author":"Meoli","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.clnu.2023.10.015_bib4","article-title":"Body composition in individuals with cystic fibrosis","volume":"26","author":"Soltman","year":"2021","journal-title":"J\u00a0Clin Transl Endocrinol [Internet"},{"issue":"APR","key":"10.1016\/j.clnu.2023.10.015_bib5","first-page":"1","article-title":"Body composition and pulmonary function in cystic fibrosis","volume":"2","author":"Sheikh","year":"2014","journal-title":"Front Pediatr"},{"issue":"8","key":"10.1016\/j.clnu.2023.10.015_bib6","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.jand.2020.03.015","article-title":"Academy of nutrition and dietetics: 2020 cystic fibrosis evidence analysis center evidence-based nutrition practice guideline","volume":"121","author":"McDonald","year":"2021","journal-title":"J\u00a0Acad Nutr Diet"},{"key":"10.1016\/j.clnu.2023.10.015_bib7","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445\u2013Tezacaftor\u2013Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles","author":"Keating","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.clnu.2023.10.015_bib8","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A\u00a0CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N\u00a0Engl J Med"},{"issue":"19","key":"10.1016\/j.clnu.2023.10.015_bib9","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013Tezacaftor\u2013Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clnu.2023.10.015_bib10","series-title":"Relationship between nutritional status and lung function in cystic fibrosis: cross sectional and longitudinal analyses from the German CF quality assurance (CFQA) project","author":"Steinkamp","year":"2002"},{"key":"10.1016\/j.clnu.2023.10.015_bib11","series-title":"Association of the relative change in weight and body mass index with lung function in teenagers and adults with cystic fibrosis: influence of gender and diabetes","author":"Cano Meg\u00edas","year":"2015"},{"key":"10.1016\/j.clnu.2023.10.015_bib12","series-title":"Association of growth and nutritional parameters with pulmonary function in cystic fibrosis: a literature review","author":"Mauch","year":"2016"},{"issue":"2","key":"10.1016\/j.clnu.2023.10.015_bib13","first-page":"376","article-title":"Assessment of body composition in cystic fibrosis: agreement between skinfold measurement and densitometry","volume":"39","author":"Contreras-Bol\u00edvar","year":"2022","journal-title":"Nutr Hosp"},{"issue":"7\u20138","key":"10.1016\/j.clnu.2023.10.015_bib14","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.nut.2009.06.026","article-title":"Fat-free mass depletion in cystic fibrosis: associated with lung disease severity but poorly detected by body mass index","volume":"26","author":"King","year":"2010","journal-title":"Nutrition"},{"issue":"6","key":"10.1016\/j.clnu.2023.10.015_bib15","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.clnu.2012.04.012","article-title":"Use of body mass index percentile to identify fat-free mass depletion in children with cystic fibrosis","volume":"31","author":"Engelen","year":"2012","journal-title":"Clin Nutr"},{"issue":"7","key":"10.1016\/j.clnu.2023.10.015_bib16","article-title":"A\u00a0review of trikafta: triple cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy","volume":"13","author":"Zaher","year":"2021","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.clnu.2023.10.015_bib17","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcf.2021.11.012","article-title":"Effect of elexacaftor-tezacaftor-ivacaftor on body weight and metabolic parameters in adults with cystic fibrosis","volume":"21","author":"Petersen","year":"2022","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.clnu.2023.10.015_bib18","article-title":"Body composition and weight changes after ivacaftor treatment in adults with cystic fibrosis carrying the G551 D cystic fibrosis transmembrane conductance regulator mutation: a double-blind, placebo-controlled, randomized, crossover study with open-label","volume":"85","author":"King","year":"2021","journal-title":"Nutrition [Internet]"},{"key":"10.1016\/j.clnu.2023.10.015_bib19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jpeds.2018.05.018","article-title":"Energy balance and mechanisms of weight gain with ivacaftor treatment of cystic fibrosis gating mutations","volume":"201","author":"Stallings","year":"2018","journal-title":"J\u00a0Pediatr"},{"issue":"6","key":"10.1016\/j.clnu.2023.10.015_bib20","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jcf.2014.09.005","article-title":"Efficacy and safety of ivacaftor in patients with cystic fibrosis and a non-G551D gating mutation","volume":"13","author":"De Boeck","year":"2014","journal-title":"J\u00a0Cyst Fibros"},{"issue":"7","key":"10.1016\/j.clnu.2023.10.015_bib21","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S2213-2600(14)70132-8","article-title":"A\u00a0CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: a phase 2 randomised controlled trial","volume":"2","author":"Boyle","year":"2014","journal-title":"Lancet Respir Med"},{"issue":"1","key":"10.1016\/j.clnu.2023.10.015_bib22","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1038\/s41598-019-38804-3","article-title":"Body fat percentage in relation to lung function in individuals with normal weight obesity","volume":"9","author":"Chen","year":"2019","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.clnu.2023.10.015_bib23","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1002\/jcsm.12821","article-title":"Relationships between lung function decline and skeletal muscle and fat mass changes: a longitudinal study in healthy individuals","volume":"12","author":"Park","year":"2021","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"issue":"4","key":"10.1016\/j.clnu.2023.10.015_bib24","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ajcn\/73.4.827","article-title":"Relation between body composition, fat distribution, and lung function in elderly men","volume":"73","author":"Santana","year":"2001","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.clnu.2023.10.015_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193516","article-title":"The longitudinal association between changes in lung function and changes in abdominal visceral obesity in Korean non-smokers","volume":"13","author":"Choe","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clnu.2023.10.015_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-020-01599-3","article-title":"Visceral adiposity index is associated with lung function impairment: a population-based study","volume":"22","author":"He","year":"2021","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.clnu.2023.10.015_bib27","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jaip.2018.11.014","article-title":"Impact of abdominal visceral adiposity on adult asthma symptoms","volume":"7","author":"Goudarzi","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561423003448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561423003448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T01:14:58Z","timestamp":1759367698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561423003448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0261561423003448"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2023.10.015","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A prospective study to assess the impact of a novel CFTR therapy combination on body composition in patients with cystic fibrosis with F508del mutation","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2023.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}